Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Other (2)
• Plasma (single spun) (5)
• Saliva (1)
• Serum (2)
• Stool (1)
• Urine (random) (3)

Microscopic Assessment

• Affected (1)
• Not applicable (5)

Storage Temperature

• RT (2)
• -85°C to -60°C (5)
• Liquid nitrogen (1)

Associated Data

• Clinical records (4)
• Followup records (4)
• Freezer temperature logs (4)
• Microbiological results (3)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (2)
• Pre-analytical data (2)
• Quality indicators (1)
• Survey data (1)
• Treatment records (5)

Timeframe

• Immediate (3)
• 0 - 3 months (4)
• 3 - 6 months (4)
• > 6 months (2)

Participant Count

• 11 - 100 (1)
• 101 - 500 (3)
• 1001 - 3000 (1)
• 10001 - 50000 (1)

Sex

• Both sexes (5)

Age Range

• Young adult (18 - 40 years) (5)

Biobank Services

• Ability to recontact (1)
• Cell culture (1)
• Data analytics (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (2)

Collection Type

• Clinical Trial (2)
• Cross-sectional (1)
• Disease specific (1)
• Population-based (1)

Consent Restriction

• No Commercial restriction (2)
• No Disease area restriction (3)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (3)

Access Condition

• Open to applicants (1)
• Open only through collaboration (4)

Country

• Democratic Republic of the Congo (2)
• France (1)
• Uganda (1)
• United States (1)

County